Detalhe da pesquisa
1.
The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP.
Scand J Clin Lab Invest
; 72(2): 137-42, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22268365
2.
Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
Platelets
; 20(7): 513-9, 2009 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-19852691
3.
Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
Diabetes Care
; 25(1): 95-100, 2002 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11772908
4.
Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria.
Kidney Int
; 68(3): 1190-8, 2005 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16105050
5.
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
Kidney Int
; 63(5): 1874-80, 2003 May.
Artigo
Inglês
| MEDLINE | ID: mdl-12675866
6.
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
J Am Soc Nephrol
; 14(4): 992-9, 2003 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12660333
7.
Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy.
Kidney Int
; 61(1): 163-8, 2002 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11786097
8.
Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.
Kidney Int
; 62(1): 220-8, 2002 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-12081581